A Fourth Covid-19 Vaccine in the U.S. Looks Likely

Numbers by Barron's - A podcast by Barron's

Categories:

Business

The FDA clears a path for Novavax. Franchise Group is in talks to buy Kohl’s. And Target’s surplus inventory is causing headaches. Host: Jackson Cantrell. Learn more about your ad choices. Visit megaphone.fm/adchoices